H.R. 1843 · 119th Congress

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Introduced on Mar 5, 2025 by Neal P. Dunn (R-FL-2). One cosponsor. Latest action (Mar 5, 2025): Referred to the House Committee on Energy and Commerce.

Stage
Introduced
Introduced
Mar 5, 2025
Cosponsors
1
1 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Neal P. DunnR-FL-2Sponsor

Democrats · 1

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Mar 5, 2025Introduced in House
  2. Mar 5, 2025Introduced in House
  3. Mar 5, 2025 · HouseReferred to the House Committee on Energy and Commerce.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. Campaign for Sustainable Drug Pricing (CSRxP)6 reports
    $300K reported (all issues)
  2. TEVA PHARMACEUTICALS USA, INC.6 reports
    Federal contractor: TEVA PHARMACEUTICALS USA, INC.$25.9M in contracts, FY2026AI match · 100%
  3. The Campaign for Sustainable Rx Pricing6 reports
    $540K reported (all issues)
  4. Viatris (Mylan, Inc)6 reports
    $360K reported (all issues)
  5. ASSOCIATION FOR ACCESSIBLE MEDICINES5 reports
    $3.9M reported (all issues)
  6. VIATRIS INC.5 reports
    $2.8M reported (all issues)
  7. Association of Accessible Medicines4 reports
    $240K reported (all issues)
  8. BCBSM, Inc.4 reports
    $118K reported (all issues)
  9. BLUE CROSS BLUE SHIELD OF MICHIGAN4 reports
    $1.1M reported (all issues)
  10. Blue Cross and Blue Shield Association4 reports
    $5.1M reported (all issues)
  11. Blue Cross and Blue Shield of Florida, Inc.4 reports
    $380K reported (all issues)
  12. GUIDEWELL MUTUAL HOLDING CORPORATION4 reports
    $30K reported (all issues)
  13. HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY4 reports
    $160K reported (all issues)
  14. BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.2 reports
    $20K reported (all issues)
  15. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA1 report

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.